NEW YORK, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Funko, Inc., PolarityTE, Inc., and MEDNAX, Inc. Stockholders have until the deadlines listed below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
Funko, Inc. (NASDAQ: FNKO)
Class Period: October 29, 2017 - June 4, 2018
Lead Plaintiff Deadline: August 27, 2018
The complaint alleges the documents filed in connection with the company’s IPO contained materially false and misleading statements and/or failed to disclose that: (1) the company’s profits and growth were not as positive as Funko represented; and (2) as a result, the company’s statements in Funko’s Registration Statement and Prospectus regarding Funko’s business, operations, and prospects were materially false and/or misleading.
To learn more about the Funko class action go to: https://bespc.com/fnko/.
PolarityTE, Inc. (NASDAQ: COOL)
Class Period: March 31, 2017 - June 22, 2018
Lead Plaintiff Deadline: August 27, 2018
The complaint alleges that on June 25, 2018, Citron Research (“Citron”) issued a report in which Citron detailed the company’s track record of material misrepresentations, misstatements, and omissions pertaining to the status of a key patent application. The Citron report noted that as far back as March 31, 2017, the USPTO notified the company of its non-final rejection of patent #14/954,335. Citron’s report continued to highlight the company’s subsequent failure to disclose the patent’s non-final rejection status and its continued behavior of representing the technology linked to the patent in a positive light. The report also pointed to the USPTO’s final rejection of the patent on June 4, 2018 information that the company also failed to disclose.
To learn more about the PolarityTE class action go to: https://bespc.com/polarityte/.
MEDNAX, Inc. (NYSE: MD)
Class Period: February 2, 2016 - July 27, 2017
Lead Plaintiff Deadline: September 10, 2018
The complaint alleges that, on July 28, 2017, Mednax announced, during its second quarter earnings call with investors and analysts, that the company failed to complete any acquisitions of anesthesiologist practices during the quarter. Significantly, the company also disclosed that any future anesthesiologist acquisitions were unlikely, which Mednax attributed to the “challenging” payor mix combined with “continued . . . growth in compensation expense for nurse anesthetists.”
To learn more about the MEDNAX class action go to: https://bespc.com/mednax/.
Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation. For additional information about Bragar Eagel & Squire, P.C. please go to www.bespc.com.
Contacts
Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Melissa Fortunato, Esq.
(212) 355-4648
investigations@bespc.com
www.bespc.com